Craig Lipset. Clinical Trials, Investments in Pharma, and Challenges of the Future

Craig Lipset leads at the forefront of innovation in clinical research and medicine development. He is an advisor to technology and biopharmaceutical companies, leading universities, and the venture community, bringing vision and driving action at the intersection of research. Craig was the Head of Clinical Innovation and Venture Partner at Pfizer.

Sergey Avdeychik, Director of Healthcare Technologies at Andersen and Member at Forbes Councils, has talked with Craig about the Healthcare market trends, clinical trial methods, prospects of investing in pharma, and other interesting aspects.

00:00 Highlights
00:43 Collaboration: benefits and prospects
05:49 Clinical trials
14:02 Andersen Charity
15:27 DTRA
21:21 AI and drug development
31:31 Investments in pharma
40:11 Digital tech
44:25 The renaissance of antiviral drugs
46:50 The war as a new challenge
48:38 Molecular profiling and new possibilities
54:13 Biobanks
57:23 Pharmacology of the future
59:32 A conspiracy theory

Charity organization «Andersen Charity»

You can also help! Join us and make a donation!

Andersen Charity on social media:

[Betty_Bee_Beth]

Thanks for the video. There's quite a lot to think about

[Max_Pashko]

Thanks a lot for the interview with Craig. Useful!

[elenatroyanova]

Thank you very much for such an interesting conversation.

[ВалентинаВолошина-жф]

beautiful, perfect, amazing, fantastic, excellent, magnificent and marvelous

[rohaneranga]

Munwa gennana obalata gu gahannaona ewasimakna ratathkala daruwange anagatheth kala ewarayi.

[moshimoshi]

Attention papa Noël, Il me semble que Mr Lemaire a bien courbé l’échine devant la Russie le lendemain de son annonce de mettre l’économie de cette dernière à genoux !!!!